DOCSLIB.ORG

Fred Sanger, Double Nobel Laureate: a Biography, by George G

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fred Sanger, Double Nobel Laureate: a Biography, by George G Downloaded from rnajournal.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press BOOK REVIEW Fred Sanger, Double Nobel Laureate: A Biography, by George G. Brownlee. 2014. Cambridge University Press. George Brownlee, the author of this book, joined Fred he did not try to invent everything, but used what was avail- Sanger as a research student in 1963 in the then new MRC able in novel ways. Thus his work on insulin depended on the Laboratory of Molecular Biology in Cambridge. Fred had de- invention of paper chromatography by Martin and Synge, cided to start work on sequencing nucleic acids and Brownlee and the dideoxy method could not have been implemented was asked to try to purify phenylalanine transfer RNA. The without the powerful technique of acrylamide gel electropho- transfer RNAs were chosen because they were small mole- resis. Although his proof that proteins had a defined chemical cules and could be purified from natural sources. Although structure was one of the cornerstones for what became mo- he failed in this task, Brownlee continued working on se- lecular biology, Fred did not take the step himself; the revo- quencing methods using the 5S RNA of E. coli, which could lution was created by Watson and Crick in 1953 with the be labeled with radioactive phosphate and the relatively small discovery of the double-helical structure of DNA, with the amounts easily purified. In his previous work, Fred had tried complementary pairing of the bases. to develop radioactive methods for sequencing proteins The intellectual drive for the creation of molecular biology because these methods reduced the amount of pure material did not come from biochemistry but from genetics. It led to required for the task. He knew that only a few proteins the concept of biological information encoded in the sequence were available in the gram quantities required for the meth- of bases in DNA and its translation through a complementary ods he developed with insulin. Furthermore, the protein sequence of mRNA into the sequence of amino acids in pro- could be labeled with radioactive tags, which allowed limited teins following the genetic code. By 1962, when Fred joined radioactive sequencing of peptides produced by enzymatic the new Laboratory of Molecular Biology, most of the basic fragmentation. problems set by the new science had been solved, and it was A good deal of this biography is based on almost verbatim therefore natural for him to choose nucleic acids for his next interviews of Fred Sanger which George Brownlee made in work. The Laboratory of Molecular Biology had a unique cul- 1992, about a decade after Fred had retired. The interviews ture, and it was called a Laboratory rather than a Unit or an cover his early life, his work on insulin in the Biochemistry Institute because it was a place where everybody worked at Department for which he won his first Nobel Prize (1958, thebench; even Francis Crick put on awhite coatwhen he tried Chemistry, for his work on the structure of proteins, especial- topurify transferRNA and when heworked on frameshift mu- ly insulin), and his work in the MRC Laboratory of Molecular tants. Because it derived from the Perutz and Kendrew group Biology on sequencing RNA and DNA for which he was in the Cavendish Laboratory with a long tradition of develop- awarded his second Nobel Prize (1980, Chemistry, jointly ing the methods for protein crystallography, it had a culture with Paul Berg and Walter Gilbert, for contributions to the that valued and appreciated new techniques. Fred fit this cul- determination of sequences in DNA). The book also has ture well and he found many other scientists who very quickly five commentaries by other scientists and an introduction recognized and appreciated what he was doing and applied his by Ed Southern; all emphasize how Fred Sanger revolution- methods to solve important biological problems. In these days ized the whole field of biological research by his inventions of heavily managed scientific research, it is hard for the bu- and discoveries. As Paul Nurse states, “Fred is one of those reaucrats of science to understand self-disciplined freedom few individuals of whom it can be said that they changed in scientific research and the great benefits it can bring not the world for ever.” only to science but to all humanity. Fred Sanger was a unique scientist who worked at the Sydney Brenner, Institute of Molecular and Cell Biology, bench right up to the end. However, like all good inventors, Singapore 138673; e-mail: [email protected] © 2016 Brenner This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available Article published online ahead of print. Article and publication date are at under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- http://www.rnajournal.org/cgi/doi/10.1261/rna.055590.115. national), as described at http://creativecommons.org/licenses/by-nc/4.0/. RNA 22:1–1; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1 Downloaded from rnajournal.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Fred Sanger, Double Nobel Laureate: A Biography, by George G. Brownlee. 2014. Cambridge University Press Sydney Brenner RNA published online January 11, 2016 P<P Published online January 11, 2016 in advance of the print journal. Creative This article is distributed exclusively by the RNA Society for the first 12 months after the Commons full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 License months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/. Email Alerting Receive free email alerts when new articles cite this article - sign up in the box at the Service top right corner of the article or click here. To subscribe to RNA go to: http://rnajournal.cshlp.org/subscriptions © 2016 Brenner Published by Cold Spring Harbor Laboratory Press for the RNA Society.
Load more

Recommended publications
  • Nobel Laureates Endorse Joe Biden
    Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S.
    [Show full text]
  • Of Charles D. Ferguson, on Behalf Of
    FEDERATION OF AMERICAN SCIENTISTS T: 202/546-3300 1725 DeSales Street, NW 6th Floor Washington, DC 20036 www.fas.org F: 202/675-1010 [email protected] PRM-70-9 DOCKETED Board of Sponsors (75FR80730) USNRC (PartialList) March 4, 2011 March 7, 2011 (10:30 am) •Pacr Agre * SidnheyAman * Philip W. Anderson *Kenneth J. Arrow To: Secretary, U.S. Nuclear Regulatory Commission OFFICE OF SECRETARY * David Baltimore RULEMAKINGS AND * Bamj Be.....ea Washington, DC 20555-0001 SPaulBerg ADJUDICATIONS STAFF * J. Michael Bishop AT-TN: Rulemakings and Adjudications Staff * Guther Blobel * Nicolaas Bloensbergen * Paul Boyce Ann Pitts Carter Subject: Comment on Docket ID NRC-2010-0372, "Petition for Rulemaking, * Stanley Cohen * Leon N. Cooper Francis Slakey on Behalf of the American Physical Society" * E. J. Corey 'James Cronin * Johann Deismehofer ArmDruyan *RenatoDulbeomo As Board Members of the Federation of American Scientists, an independent, Paul L Ehrlich George Field nonpartisan think tank, we strongly support the petition submitted by the Vat L. Fitch * JeromeI. Friedman American Physical Society that requests proliferation risk assessments become a * Riccardo Giacoani * Walter Gilbert required part of the NRC licensing process. * Alfed G. Gilman " Donald Glaser * Sheldon L. Glashow Marvin L. Goidhergr * Joseph L. Goldstein Emerging nuclear fuel technologies such as laser enrichment of uranium can pose Roger C. L. Gaillemin * L[land H. Hartwell significant proliferation risks due to difficulties in detecting facilities using these * Herbert A. Hauptman " Dudley RKHIaechach technologies. If such technologies are developed without a clear, objective, and * Roald Hoff-aan John P. Hoidren detailed assessment, they can dangerously undermine U.S. nuclear * -l Robert Horvitz * David H.
    [Show full text]
  • THE GENOMIC SEQUENCING TECHNIQUE George M. Church
    Medical Genetics: Past, Present, Future, pages 17-21 © 1985 Alan R. Llss , Inc. THE GENOMIC SEQUENCING TECHNIQUE George M. Church and Walter Gilbert Biogen Cambridge , Massachusetts 02 142 In a mammalian cell , the DNA corresponding to any gene sequence is surrounded by DNA corr esponding to some million other such sequences. How can we study a specific gene without isolating it away from al l others? We have devised a technfque that will display the se quence of any gene without previous purification (Ch urch and Gilbert 1983) . Our method extends the Southern blotting technique to a new degree of sensitivity . \.J'e use a radioactive probe not just to identify a single r estriction fragment of DNA but as a way of end-labeling a unique restriction fragment. This end- label ing by hybridization is analogous to the end- labeling that we do in the conventional DNA sequencing , which enables us to display in any partial digest a series of fragments extending out f r om the point of label ing as a series of labeled bands separated by size . Although the chemical DNA sequencing techniques usually use onl y a single labeled phosphate, if the hybridization probe is kept moderately short, on the order of 100 nucleotides , it will serve as a end- label that can display sequence running out several hundred bases beyond the end of the probe . We take total DNA and cut it with a restr iction enzyme, one of .whose cuts is close to the sequence of interest. After we perform the chemical sequencing reactions on that total DNA, we electrophorese the ~enatured DNA through a conventional sequencing gel.
    [Show full text]
  • Congressional Record—Senate S6593
    July 13, 2000 CONGRESSIONAL RECORD Ð SENATE S6593 E. J. Corey, Harvard University, 1990 Nobel The PRESIDING OFFICER. The Sen- AMENDMENT NO. 3753 Prize in chemistry. ator from Mississippi. Mr. ROCKEFELLER. Mr. President, I James W. Cronin, University of Chicago, Mr. COCHRAN. Mr. President, the am pleased that the Senate has taken 1980 Nobel Prize in physics. an important step toward protecting Renato Dulbecco, The Salk Institute, 1975 Durbin amendment is unnecessary. It Nobel Prize in medicine. purports to direct the manner and de- the lives and property of all Americans Edmond H. Fischer, Univ. of Washington, tails of a missile testing program that with the passage of the Firefighter In- 1992 Nobel Prize in medicine. the Secretary of Defense is committed vestment and Response Enhancement Val L. Fitch, Princeton University, 1980 to conduct already. Act. I am proud today to join with Sen- Nobel Prize in physics. This amendment is an unprecedented ators DODD and DEWINE as a cosponsor Robert F. Furchgott, Suny Health Science effort by the Senate to micromanage a of this legislation. I wish to thank Sen- Ctr., 1998 Nobel Prize in medicine. ator DODD and Senator DEWINE for the Murray Gell-Mann, Santa Fe Institute, weapons system testing program. In no 1969 Nobel Prize in physics. other program has the Senate tried to leadership and effort they have shown Ivar Giaever, Rensselaer Polytechnic Insti- legislate in this way to dictate to DOD on behalf of the men and women serv- tute, 1973 Nobel Prize in physics. how a classified national security test- ing as firefighters across the nation.
    [Show full text]
  • Open Letter to the American People
    FOR IMMEDIATE RELEASE: October 18, 2016 AN OPEN LETTER TO THE AMERICAN PEOPLE The coming Presidential election will have profound consequences for the future of our country and the world. To preserve our freedoms, protect our constitutional government, safeguard our national security, and ensure that all members of our nation will be able to work together for a better future, it is imperative that Hillary Clinton be elected as the next President of the United States. Some of the most pressing problems that the new President will face — the devastating effects of debilitating diseases such as Alzheimer’s disease and cancer, the need for alternative sources of energy, and climate change and its consequences — require vigorous support for science and technology and the assurance that scientific knowledge will inform public policy. Such support is essential to this country’s economic future, its health, its security, and its prestige. Strong advocacy for science agencies, initiatives to promote innovation, and sensible immigration and education policies are crucial to the continued preeminence of the U.S. scientific work force. We need a President who will support and advance policies that will enable science and technology to flourish in our country and to provide the basis of important policy decisions. For these reasons and others, we, as U.S. Nobel Laureates concerned about the future of our nation, strongly and fully support Hillary Clinton to be the President of the United States. Peter Agre, Chemistry 2003 Carol W. Greider, Medicine 2009 Sidney Altman, Chemistry 1989 David J. Gross, Physics 2004 Philip W. Anderson, Physics 1977 Roger Guillemin, Medicine 1977 Kenneth J.
    [Show full text]
  • Federation of American Scientists
    FEDERATION OF AMERICAN SCIENTISTS T: 202/546-3300 1717 K Street NW #209 Washington, DC 20036 www.fas.org F: 202/675-1010 [email protected] Board of Sponsors (Partial List) November 12, 2001 *Sidney Altman *Philip W. Anderson Hon Tom Daschle Hon J. Dennis Hastert *Kenneth J. Arrow *Julius Axelrod Senate Majority Leader Speaker of the House *David Baltimore *Baruj Benacerraf *Hans A. Bethe *J. Michael Bishop Hon Trent Lott Hon Richard Gephardt *Nicolaas Bloembergen *Norman Borlaug Senate Minority Leader House Minority Leader *Paul Boyer Ann Pitts Carter *Owen Chamberlain In the interest of national security we urge you to deny funding for any program, project, or Morris Cohen *Stanley Cohen activity that is inconsistent with the Anti-Ballistic Missile (ABM) Treaty. The tragic events Mildred Cohn *Leon N. Cooper of September 11 eliminated any doubt that America faces security needs far more substantial *E. J. Corey *James Cronin than a technically improbable defense against a strategically improbable Third World *Johann Deisenhofer ballistic missile attack. Ann Druyan *Renato Dulbecco John T. Edsall Paul R. Ehrlich Regarding the probable threat, the September 11 attacks have dramatized what has been George Field obvious for years: A primitive ICBM, with its dubious accuracy and reliability and bearing *Val L. Fitch *Jerome I. Friedman a clear return address, is unattractive to a terrorist and a most improbable delivery system for John Kenneth Galbraith *Walter Gilbert a terrorist weapon. Devoting massive effort and expense to countering the least probable *Donald Glaser and least effective threat would be unwise. *Sheldon L. Glashow Marvin L. Goldberger *Joseph L.
    [Show full text]
  • Programme 70Th Lindau Nobel Laureate Meeting 27 June - 2 July 2021
    70 Programme 70th Lindau Nobel Laureate Meeting 27 June - 2 July 2021 Sessions Speakers Access Background Scientific sessions, Nobel Laureates, Clear guidance Everything else social functions, young scientists, to all viewing there is to know partner events, invited experts, and participation for a successful networking breaks moderators options meeting 2 Welcome Two months ago, everything was well on course to celebrate And yet: this interdisciplinary our 70th anniversary with you, in Lindau. anniversary meeting will feature But with the safety and health of all our participants being the most rich and versatile programme ever. of paramount importance, we were left with only one choice: It will provide plenty of opportunity to educate, inspire, go online. connect – and to celebrate! Join us. 4 PARTICIPATING LAUREATES 4 PARTICIPATING LAUREATES 5 Henry A. Joachim Donna George P. Hartmut Michael M. Adam Hiroshi Kissinger Frank Strickland Smith Michel Rosbash Riess Amano Jeffrey A. Peter Richard R. James P. Randy W. Brian K. Barry C. Dean Agre Schrock Allison Schekman Kobilka Barish John L. Harvey J. Robert H. J. Michael Martin J. Hall Alter Grubbs Kosterlitz Evans F. Duncan David J. Ben L. Edmond H. Carlo Brian P. Kailash Elizabeth Haldane Gross Feringa Fischer Rubbia Schmidt Satyarthi Blackburn Robert B. Reinhard Aaron Walter Barry J. Harald Takaaki Laughlin Genzel Ciechanover Gilbert Marshall zur Hausen Kajita Christiane Serge Steven Françoise Didier Martin Nüsslein- Haroche Chu Barré-Sinoussi Queloz Chalfie Volhard Anthony J. Gregg L. Robert J. Saul Klaus William G. Leggett Semenza Lefkowitz Perlmutter von Klitzing Kaelin Jr. Stefan W. Thomas C. Emmanuelle Kurt Ada Konstantin S.
    [Show full text]
  • A Tribute to Cold Spring Harbor Laboratory on Its 100Th Birthday
    EUGENE GARFIELD IN ST ItUTE FoR SCIENTIFIC IN FOe M.4T10N@ 3501 MARKET ST PHILADELPHIA PA 19104 A Tribute to Cold Spring Harbor Laboratory 011 Its IO(MI Biih(ky: Jan A. Witkowski Reviews Its HisEory and the Highest Impact Sympsia Publications Number 28 July 9, 1990 In March of this year, i%e Scienrist@pre- University of Southampton in 1968 and a sented a survey of small, independent re- PhD in biochemistry from the University of search institutions in the US. 1Twenty such London in 1972. Between 1972 and 1982 institutions were ranked by the citation im- he was a research fellow at the Institute of pact of their papers published between 1973 Child Health, London, and at the Mayo and 1987. Although the Salk Institute for Clinic, Rochester, Mimesota. From 1982 Biological Studies and the Scripps Clinic and to 1986, he was a lecturer in the Department Research Foundation, both of San Diego, of Pediatrics, Royal Postgraduate Medical California, received the most citations (over School, University of London. He then 124,000 each), the institution that topped the served as director, Kleberg DNA Diagnostic list by citation impact was the Cold Spring Laboratory, and assistant professor, Institute Harbor Laborato~, New York. As David for Molecular Genetics, at Baylor College Pendlebury observed, papers published from of Medicine, Houston, Texas. Cold Spring Harbor had a citation impact Witkowski came to Cold Spring Harbor more than five times greater than the average in 1987. As director of the Banbury Center, for the entire Science Citation Indexm data- he determines topics for conferences at the base.
    [Show full text]
  • Allis Kornberg
    Ada Doisy Lecturers 2006 Ada Doisy Lectures 1970-71 Charles Huggins* and Elwood V. Jensen 2007 in BIOCHEMISTRY 1972-73 Paul Berg* and Walter Gilbert* Sponsored by the Department of Biochemistry • University of Illinois at Urbana-Champaign 1973-74 Saul Roseman and Bruce Ames 1974-75 Arthur Kornberg* and Osamu Hayaishi Dr. Roger 1976-77 Luis F. Leloir* 1977-78 Albert L. Lehninger and Efraim Racker Kornberg Department of Biochemistry 1978-79 Donald D. Brown and Herbert Boyer Stanford School of Medicine 1979-80 Charles Yanofsky Stanford, California 1980-81 Leroy E. Hood 1983-84 Joseph L. Goldstein* and Michael S. Brown* 1984-85 Joan Steitz and Phillip Sharp* The Molecular Basis of 1985-86 Stephen J. Benkovic and Jeremy R. Knowles Eukaryotic Transcription 1986-87 Tom Maniatis and Mark Ptashne 1988-89 J. Michael Bishop* and Harold E. Varmus* 1989-90 Kurt Wüthrich* 4:00 p.m. Thursday, April 5, 2007 1990-91 Edmond H. Fischer* and Edwin G. Krebs* Medical Sciences Auditorium 1993-94 Bert W. O’Malley 1994-95 Earl W. Davie and John W. Suttie 1995-96 Richard J. Roberts* Dr. C. David 1996-97 Ronald M. Evans 1998-99 Elizabeth H. Blackburn Allis 1999-2000 Carl R. Woese† and Norman R. Pace Department of Molecular and Cellular Physiology The Rockefeller University 2000-01 Willem P. C. Stemmer and Ronald W. Davis New York, New York 2001-02 Janos K. Lanyi and Sir John E. Walker* 2002-03 Peter B. Moore and Harry F. Noller 2003-04 Elizabeth A. Craig and Susan L. Lindquist Beyond the Double Helix: 2004-05 Peter C.
    [Show full text]
  • DNA Sequencing with Chain-Terminating Inhibitors
    http://philos.biol.mun.ca/%7Eb4241/4241_ayk/ DNA sequencing with chain-terminating inhibitors F. Sanger, S. Nicklen, and A. R. Coulson Presented by Kim Butt, Yumiko Komatsu, and Amelia Parrott Nobel Prize in Chemistry (1980) "for his fundamental studies of the biochemistry of nucleic acids, with particular regard to recombinant-DNA" "for their contributions concerning the determination of base sequences in nucleic acids" Paul Berg Walter Gilbert Fred Sanger DNA Sequencing Timeline 1953 – Structure of DNA double helix deduced by Watson and Crick 1972 – Development of recombinate DNA technology by Berg 1975 – Plus and minus method of DNA sequencing developed by Sanger 1977 – DNA sequencing dideoxy method developed by Sanger 1986 – PCR developed by Mullis 1986 – First semi-automated DNA sequencing machine announced http://philos.biol.mun.ca/%7Eb4241/4241_ayk/ 2000 – Drosophila genome is completed 2003 – Human genome sequence is released The Dideoxy Method PRINCIPLE BEHIND THE METHOD Sanger method - DNA sequencing using chain-terminating inhibitors to terminate DNA synthesis at a specific site - also known as the dideoxy method How did Sanger come up with this method? Method 1. Preparation of ddNTPs Complex chemistry Now: A lot of materials are commercially available 2. Sequencing procedure: Chain termination method: Primer annealed to tDNA in H buffer Template DNA from Phage Phi X174 Make 5 separate mixtures and incubate as follows: dATP chase—put additional dATP into each of the tube & incubate. A critical step to avoid random termination at A residues Figure 1: Small primer, no further splitting required Figure 2: Longer primer, further splitting was necessary to separate the primer from synthesized DNA.
    [Show full text]
  • TRINITY 2005 Contents
    Fusion #4f 10/6/05 1:42 pm Page 2 fusionTHE NEWSLETTER OF THE SIR WILLIAM DUNN SCHOOL OF PATHOLOGY ISSUE 4 . TRINITY 2005 Contents Editorial 1 Editorial News 2 Anyone reading William James’s article on the history of Virology at the Dunn School Virology at the will not fail to notice his ‘aside’ speculation on why the Dunn School has been such a Dunn School 4 successful contributor to medical science and fundamental biology. It has always been an Institute without Divisions, and has consequently fostered strong interdisciplinary Albert Beyers 6 science. You, Me and HIV 7 Our strong publication record and success in attract senior figures in the areas of the raising grant funding attests to the success of molecular basis of cancer, and in cell-signalling. Jim Gowans that philosophy. This is, of course, a structure To achieve the former the Division has agreed to recirculated 8 which carries some risks, as certain important allow the department to fundraise for the Research Notes 9 areas may go through periods when the "active creation of the César Milstein Chair in Molecular Basis of Cancer. César Milstein was an old friend mass" in a given area would seem small. In Overcoming antibiotic recent years the department has had the of the department, and his discovery of resistance 10 satisfaction of seeing that some of its star monoclonal antibodies opened up many fields of scientists have moved to occupy important medical science for which many of his friends Fishing for leadership positions in other British Universities here are enormously grateful.
    [Show full text]
  • Single-Molecule FRET Reveals a Corkscrew RNA Structure for the Polymerase-Bound Influenza Virus Promoter
    Single-molecule FRET reveals a corkscrew RNA PNAS PLUS structure for the polymerase-bound influenza virus promoter Alexandra I. Tomescua,1, Nicole C. Robba,1, Narin Hengrungb,c, Ervin Fodorb,2, and Achillefs N. Kapanidisa,2 aBiological Physics Research Group, Clarendon Laboratory, Department of Physics, University of Oxford, Oxford OX1 3PU, United Kingdom; bSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom; and cDivision of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom Edited by Robert A. Lamb, Northwestern University, Evanston, IL, and approved July 8, 2014 (received for review April 1, 2014) The influenza virus is a major human and animal pathogen re- development of specific antiviral agents, such as decoy RNAs sponsible for seasonal epidemics and occasional pandemics. The (10). Despite this, little structural information is available re- genome of the influenza A virus comprises eight segments of single- garding the mechanisms of RNA promoter recognition and stranded, negative-sense RNA with highly conserved 5′ and 3′ ter- binding by the influenza virus RNAP. mini. These termini interact to form a double-stranded promoter During the influenza virus life cycle, the viral RNAP tran- structure that is recognized and bound by the viral RNA-dependent scribes the vRNA genome into capped and polyadenylated RNA polymerase (RNAP); however, no 3D structural information for mRNAs using short primers containing a 5′ 7-methyl-guanosine the influenza polymerase-bound promoter exists. Functional studies cap structure derived from host cell pre-mRNAs. The vRNA have led to the proposal of several 2D models for the secondary segments are also replicated by the RNAP via cRNA inter- structure of the bound promoter, including a corkscrew model in mediates, which in turn are used as templates to make more ′ ′ which the 5 and 3 termini form short hairpins.
    [Show full text]